Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05700994 · ClinicalTrials.gov registry record · NA

Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)

A NA study of Methamphetamine Abuse, sponsored by Oregon Health and Science University.

Active
Registry status
NA
Development phase
1,283
Enrollment target
2
Study locations

NCT05700994 is a NA study of Methamphetamine Abuse that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 1,283 participants, above the 123-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (943% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05700994, a NA study of Methamphetamine Abuse, is active but no longer recruiting, sponsored by Oregon Health and Science University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,283 participants
Enrollment target
2
Study locations

Study Summary

The main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and effectiveness of methamphetamine (MA) harm reduction services.

Conditions Studied

Interventions

  • BEHAVIORAL Peer Contingency Management
  • BEHAVIORAL Standard of Care Contingency Management

Study Locations (2)

Oregon

  • Comagine Health - Portland
  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 1,283 participants
Start Date 2023-11-13
Est. Completion 2026-09-30
Phase NA

What the Registry Record Tells You About NCT05700994

The ClinicalTrials.gov registry entry for NCT05700994 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,283 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 123-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (943% higher). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Methamphetamine Abuse appearing as the primary indexed condition, and to 2 interventions - of which Peer Contingency Management is the first listed.

NCT05700994 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT05700994 about?

NCT05700994 is a clinical study titled "Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)". The main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and effectiveness of met...

What is the current status of trial NCT05700994?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,283 participants. The study started on 2023-11-13. Estimated completion is 2026-09-30.

What conditions does trial NCT05700994 study?

This clinical trial studies the following conditions: Methamphetamine Abuse.

What interventions are being tested in trial NCT05700994?

The interventions under investigation include: Peer Contingency Management (BEHAVIORAL), Standard of Care Contingency Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT05700994?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05700994 being conducted?

This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Methamphetamine Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.